newsfilter
← Latest News
GlobeNewswire·

Century Therapeutics Appoints Joseph Truitt to Board of Directors

PHILADELPHIA, Sept. 09, 2026 (GLOBE NEWSWIRE) -- Century Therapeutics, Inc. ((‘Century’, NASDAQ:IPSC), a biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies for autoimmune